JOURNAL OF INHERITED METABOLIC DISEASE

Scope & Guideline

Uncovering the Secrets of Metabolic Disorders

Introduction

Immerse yourself in the scholarly insights of JOURNAL OF INHERITED METABOLIC DISEASE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0141-8955
PublisherWILEY
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1978 to 2024
AbbreviationJ INHERIT METAB DIS / J. Inherit. Metab. Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The JOURNAL OF INHERITED METABOLIC DISEASE focuses on advancing knowledge and treatment options for inherited metabolic disorders through rigorous research and clinical studies. Its primary aim is to disseminate findings that improve diagnosis, management, and understanding of these complex conditions.
  1. Inherited Metabolic Disorders:
    The journal covers a broad range of inherited metabolic diseases, including but not limited to urea cycle disorders, lysosomal storage diseases, and fatty acid oxidation disorders.
  2. Clinical Research and Trials:
    It emphasizes clinical studies and trials aimed at evaluating new treatments, therapies, and diagnostic methods for patients with inherited metabolic diseases.
  3. Biochemical and Genetic Analysis:
    Research articles often focus on biochemical pathways, genetic mutations, and their implications for disease phenotype and management.
  4. Newborn Screening and Early Diagnosis:
    The journal highlights advancements in newborn screening techniques and their impact on early diagnosis and intervention strategies.
  5. Patient-Centered Research:
    There is a strong focus on the psychosocial aspects of living with inherited metabolic disorders, including quality of life, caregiving challenges, and patient-reported outcomes.
The JOURNAL OF INHERITED METABOLIC DISEASE has identified several trending and emerging themes that reflect the evolving landscape of research in inherited metabolic disorders. These areas highlight innovative approaches and growing concerns within the field.
  1. Gene Therapy and Genetic Interventions:
    There is a significant surge in research focused on gene therapy as a potential treatment for various inherited metabolic disorders, showcasing promising advancements in this area.
  2. Precision Medicine and Personalized Treatment:
    Emerging studies are increasingly focusing on precision medicine approaches, tailoring treatments based on individual genetic and biochemical profiles.
  3. Metabolomics and Biomarker Discovery:
    Research in metabolomics is on the rise, aiming to identify novel biomarkers that can aid in the diagnosis and monitoring of metabolic diseases.
  4. Patient-Centric Approaches:
    A growing trend towards incorporating patient perspectives and experiences in research design and outcomes assessment is evident, emphasizing the importance of patient-reported outcomes.
  5. Newborn Screening Innovations:
    Recent publications highlight innovations in newborn screening methodologies, indicating a shift towards more comprehensive and effective early detection strategies.

Declining or Waning

While the JOURNAL OF INHERITED METABOLIC DISEASE continues to explore a wide array of topics, certain themes have shown a decline in research focus over recent years. These waning scopes reflect shifting interests in the field, possibly due to advancements in understanding and treatment options.
  1. Traditional Biochemical Methods:
    There is a noticeable decline in the publication of studies relying solely on traditional biochemical assays for diagnosis, as newer genomic and metabolomic approaches gain prominence.
  2. Animal Models for Basic Research:
    Research focused on animal models for understanding metabolic diseases has decreased, possibly due to a shift toward more translational and clinical research.
  3. Historical Perspectives on Disorders:
    Papers providing historical context or retrospective analyses of inherited metabolic diseases are less frequent, indicating a move towards contemporary and forward-looking studies.
  4. General Reviews of Inherited Disorders:
    The journal has seen fewer general review articles on inherited metabolic disorders, as the focus shifts to specific case studies and novel therapeutic approaches.
  5. Epidemiological Studies:
    There has been a noticeable reduction in the frequency of purely epidemiological studies, as more emphasis is placed on clinical outcomes and intervention trials.

Similar Journals

Annual Review of Genomics and Human Genetics

Leading the Charge in Genomic and Genetic Research
Publisher: ANNUAL REVIEWSISSN: 1527-8204Frequency: 1 issue/year

Annual Review of Genomics and Human Genetics, published by ANNUAL REVIEWS, represents a pivotal platform in the field of Genetics and Molecular Biology. With an impressive impact factor reflecting its high citation rate and scholarly influence, this journal is renowned for its authoritative reviews that synthesize current research across genomics and human genetics. Highlighting its Q1 category rankings in both Genetics and Clinical Genetics, as well as its ranking within the top tiers of Biochemistry and Genetics, the journal stands out as a leading resource for researchers, professionals, and students eager to stay abreast of groundbreaking developments in these rapidly evolving fields. While not currently an open access journal, its rigorous peer-review process ensures the highest standards of scientific integrity. Researchers can access comprehensive reviews that delve into both fundamental genetics concepts and cutting-edge discoveries, making it an essential resource for advancing understanding in human genetics and its applications.

OPHTHALMIC GENETICS

Bridging Genetics and Vision Care for a Brighter Tomorrow
Publisher: TAYLOR & FRANCIS INCISSN: 1381-6810Frequency: 4 issues/year

OPHTHALMIC GENETICS is a distinguished journal published by TAYLOR & FRANCIS INC, specializing in the intersection of genetics and ophthalmology. Established in 1981, the journal has become a vital resource for researchers, clinicians, and students interested in the genetic aspects of eye diseases and disorders. Despite not being an Open Access journal, it maintains a commendable impact within the academic community, as reflected by its Q3 ranking in clinical genetics and Q2 rankings in both ophthalmology and pediatrics in 2023. With a robust focus on clinical applications, OPHTHALMIC GENETICS aims to provide a platform for innovative research and insights that drive advancements in patient care and understanding of genetic conditions affecting vision. The journal's international readership is supported by its timely publication of articles that bridge the gap between genetic research and practical ophthalmological applications.

Boletin de Pediatria

Fostering Collaboration for a Healthier Tomorrow
Publisher: EDICIONES ERGON SAISSN: 0214-2597Frequency: 4 issues/year

Boletin de Pediatria is a distinguished journal dedicated to the field of pediatric medicine, serving as a valuable resource for researchers, clinicians, and students alike. Published by EDICIONES ERGON SA, this journal is committed to advancing the knowledge and practice of pediatric healthcare. With its ISSN 0214-2597 and E-ISSN 2340-5384, it strives to disseminate high-quality, peer-reviewed research that addresses the latest advancements and best practices in pediatrics. Although specific impact factor data is not currently available, the journal's rigorous publication standards maintain its reputation within the scientific community. Notably, while Boletin de Pediatria is not an open-access journal, it provides digital access options that ensure the wide distribution of critical pediatric research. With a commitment to improving child health outcomes, this journal plays an essential role in fostering innovation and collaboration among pediatric healthcare professionals globally.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Exploring the Depths of Genetic Knowledge
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Fostering Global Dialogue in Eye Care Science
Publisher: WILEYISSN: 1442-6404Frequency: 9 issues/year

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

GYNECOLOGICAL ENDOCRINOLOGY

Pioneering Studies for a Healthier Future in Gynecology
Publisher: TAYLOR & FRANCIS LTDISSN: 0951-3590Frequency: 12 issues/year

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

LymphoSign Journal-The Journal of Inherited Immune Disorders

Pioneering Research for a Healthier Tomorrow
Publisher: LYMPHOSIGN JOURNAL LTD PARTNERSHIPISSN: 2292-5937Frequency: 4 issues/year

LymphoSign Journal - The Journal of Inherited Immune Disorders is a pivotal resource for researchers and professionals focused on the intricate field of immunology, specifically the study of inherited immune disorders. Published by LYMPHOSIGN JOURNAL LTD PARTNERSHIP, this journal serves as an open-access platform aimed at disseminating high-quality research that contributes to the understanding, diagnosis, and treatment of immunological conditions. With an emphasis on novel findings and clinical applications, LymphoSign Journal plays a crucial role in bridging the gap between research and practical solutions in healthcare. The journal's ISSN 2292-5937 and E-ISSN 2292-5945 ensure wide accessibility and recognition in academic databases, fostering collaboration and innovation within the global scientific community.

JOURNAL OF MEDICAL GENETICS

Elevating Understanding of Genetic Disorders Through Rigorous Research.
Publisher: BMJ PUBLISHING GROUPISSN: 0022-2593Frequency: 12 issues/year

JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Unveiling the Future of Endocrine Research and Practice
Publisher: ENDOCRINE SOCISSN: 0021-972XFrequency: 12 issues/year

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

CLINICAL GENETICS

Pioneering insights into clinical genetics.
Publisher: WILEYISSN: 0009-9163Frequency: 12 issues/year

CLINICAL GENETICS is a premier journal in the field of genetics, published by Wiley, and is renowned for advancing the understanding of genetic disorders and their clinical applications. With a notable impact factor and ranking in the top quartile (Q1) in both general genetics and clinical genetics as of 2023, this journal is instrumental for researchers, professionals, and students seeking to explore groundbreaking studies and developments in genetics. Since its inception in 1970, CLINICAL GENETICS has continued to publish high-quality, rigorously peer-reviewed research that pushes the boundaries of knowledge in clinical genetics. The journal maintains a strong reputation in its field, currently holding significant positions in Scopus rankings, including 30th out of 99 in clinical genetics, underscoring its relevance and impact in the field. For those interested, the journal's website provides comprehensive access options for current and archived research, making it an essential resource for anyone involved in genetic research and its clinical application.